Dan Moskowitz, MD
Facial Plastic Surgery · Rye, NYNPI 1508805326
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by GSK at 35.3% of the total.
Across 77 payments — averaging $21.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$595
- Optinose US, Inc.$455
- Novartis$308
- Inspire Medical Systems, Inc.$87
- Stryker$77
- AbbVie$47
- plus $118 from 7 others
What the payments were for
- Food & beverage$1,687100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 22 | $595 |
| Optinose US, Inc. | 23 | $455 |
| Novartis | 17 | $308 |
| Inspire Medical Systems, Inc. | 3 | $87 |
| Stryker | 2 | $77 |
| AbbVie | 3 | $47 |
| Neurent Medical Limited | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Smith+Nephew | 1 | $18 |
| Grifols USA, LLC | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| AstraZeneca | 1 | $14 |
| Kaleo, Inc. | 1 | $13 |
How this compares
$1,687 in reported general payments places this provider in the 55th percentile of 48 facial plastic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 187 | $4,267 |
| Fluticasone Propionate | 155 | $1,706 |
| Famotidine | 125 | $1,663 |
| Pantoprazole Sodium | 121 | $1,470 |
| Ipratropium Bromide | 59 | $1,376 |
| Cefdinir | 61 | $1,123 |
| Rabeprazole Sodium | 16 | $913 |
| Ofloxacin | 24 | $761 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 59 | $495 |
| Methylprednisolone | 70 | $481 |
| Fluocinolone Acetonide Oil | 14 | $451 |
| Doxycycline Hyclate | 35 | $404 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $280 |
| Azithromycin | 60 | $262 |
| Triamcinolone Acetonide | 40 | $161 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Rye
- Ran RubinsteinNewburgh$330K
- Joshua RosenbergNew York$61K
- Allison PontiusNew York$55K
- Michael CohenSyosset$10K
- Daniel LeeLatham$10K
- Lesley RabachNew York$9K
- B SchaefferNew Hyde Park$8K
- Michael BergsteinTarrytown$8K
- Daniel DemeshNew York$6K
- Steven PearlmanNew York$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.